Business Context and Reporting Period
This Form 8-K Current Report was filed by Acadia Healthcare Company, Inc. on March 12, 2026, covering events occurring on March 9, 2026, and March 12, 2026. The filing addresses changes to the composition of the Company's Board of Directors.
Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Board Retirement: Wade Miquelon informed the Board on March 9, 2026, of his decision to retire as a director, effective at the 2026 Annual Meeting of Stockholders. He will not stand for reelection. The retirement is not the result of any disagreement with the Company.
- Board Appointment: On March 12, 2026, the Board increased its size from 10 to 11 members and appointed Daniel Cancelmi as a Class III director, effective immediately. Mr. Cancelmi will serve on the Audit Committee.
- Board Size Adjustment: The Board approved a reduction in size from 11 back to 10 members, effective upon Mr. Miquelon's retirement at the 2026 Annual Meeting.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. No new risks or contingencies were disclosed. The appointment of Mr. Cancelmi is subject to the Company's existing compensation plan for non-employee directors, with no undisclosed arrangements or family relationships noted.
Key Facts for Investor Verification
- Verify the exact date of the 2026 Annual Meeting to confirm the effective date of Mr. Miquelon's retirement.
- Review the definitive proxy statement for the 2025 annual meeting (filed April 10, 2025) for details on the director compensation plan applicable to Mr. Cancelmi.
- Confirm the final composition of the Audit Committee following Mr. Cancelmi's appointment.